Review



ca19-9 level  (Wolters Kluwer Health)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Wolters Kluwer Health ca19-9 level
    Ca19 9 Level, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/ca19+9/10__1097_slash_sla__0000000000006209-114-10-25
    Average 90 stars, based on 1 article reviews
    ca19-9 level - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Prospective Evaluation of Circulating Tumor DNA using Next Generation Sequencing as a Biomarker during Neoadjuvant Chemotherapy in Localized Pancreatic Cancer
    Article Snippet: Prospective evaluation of Circulating Tumor DNA using Next Generation Sequencing as a Biomarker during Neoadjuvant Chemotherapy in Localized Pancreatic Cancer Dhavan Shah MD1, Amy Wells MS4, Madison Cox BS3, Kevin Dawravoo MD3, John Abad MD2,3, Arlene D’Souza MD3, Grace Suh MD3, Robert Bayer MD3, Sohail Chaudhry MD3, Qiang Zhang M.D.4, Massimo Cristofanilli MD.5, David Bentrem MD2,4, Akhil Chawla MD1,2,3,4 1 Northwestern Quality Improvement, Research & Education in Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 2 Division of Surgical Oncology, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 3 Northwestern Medicine Cancer Centers, Northwestern Medicine Regional Medical Group, Winfield, IL 4 Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 5 Division of Medical Oncology, Internal Medicine Department, Weill Cornell Medicine, New York, NY Keywords: Pancreatic cancer; next generation sequencing; circulating tumor DNA; biomarker; neoadjuvant chemotherapy Conflicts of Interest and Source of Funding: Dr. Shah is a postdoctoral fellow supported by a NIH/NCI training grant (R38CA245095).. This work was supported by The Elsa U. Pardee Foundation Grant – PI Akhil Chawla, MD.. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.



    Similar Products

    human serum ca19 9 level  (Tosoh Corporation)
    86
    Tosoh Corporation human serum ca19 9 level
    Human Serum Ca19 9 Level, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/9+ca19/us12448654-410-0-11
    Average 86 stars, based on 1 article reviews
    human serum ca19 9 level - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    analysis of serum tfpi2, ca125, ca19-9, and cea levels  (Tosoh Corporation)
    90
    Tosoh Corporation analysis of serum tfpi2, ca125, ca19-9, and cea levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Analysis Of Serum Tfpi2, Ca125, Ca19 9, And Cea Levels, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/tfpi2+elisa+kit/pmc11351603-278-20-29
    Average 90 stars, based on 1 article reviews
    analysis of serum tfpi2, ca125, ca19-9, and cea levels - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    ca19-9 level  (Tosoh Corporation)
    90
    Tosoh Corporation ca19-9 level
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Level, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/ca19+9/us12037647-412-0-11
    Average 90 stars, based on 1 article reviews
    ca19-9 level - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    ca19-9 levels  (Johns Hopkins HealthCare)
    90
    Johns Hopkins HealthCare ca19-9 levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Levels, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/ca19+9+tumor+marker+gene+test/pmc11191066-83-18-24
    Average 90 stars, based on 1 article reviews
    ca19-9 levels - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    ca19-9 level  (Wolters Kluwer Health)
    90
    Wolters Kluwer Health ca19-9 level
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Level, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/ca19+9/10__1097_slash_sla__0000000000006209-114-10-25
    Average 90 stars, based on 1 article reviews
    ca19-9 level - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    ca19 9 concentration serum levels  (Thermo Fisher)
    86
    Thermo Fisher ca19 9 concentration serum levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Concentration Serum Levels, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/pmc08243252__HEP___73___144___s001-81-0-9
    Average 86 stars, based on 1 article reviews
    ca19 9 concentration serum levels - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    serum ca19-9 levels  (SATAKE)
    90
    SATAKE serum ca19-9 levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Serum Ca19 9 Levels, supplied by SATAKE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/carbohydrate+antigen+19+9/pmc07409286-97-4-0
    Average 90 stars, based on 1 article reviews
    serum ca19-9 levels - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    scc, ca125, ca19-9 levels  (Takeda)
    90
    Takeda scc, ca125, ca19-9 levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Scc, Ca125, Ca19 9 Levels, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/serum+ca125+levels/pm30052166-237-13-0
    Average 90 stars, based on 1 article reviews
    scc, ca125, ca19-9 levels - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    ca19 9 levels  (Cusabio)
    85
    Cusabio ca19 9 levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Levels, supplied by Cusabio, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/Human+carbonhydrate+antigen+19-9+(CA19-9)+ELISA+kit/pm27223429-111-30-42
    Average 85 stars, based on 1 article reviews
    ca19 9 levels - by Bioz Stars, 2026-10
    85/100 stars
    		  Buy from Supplier
    ca19 9 levels  (Monobind)
    94
    Monobind ca19 9 levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Levels, supplied by Monobind, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca19-9+level/Recovered+Plasma+-+Defibrinated/pm28232049-111-9-27
    Average 94 stars, based on 1 article reviews
    ca19 9 levels - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups

    Article Snippet: The other authors declare no conflicts of interest directly relevant to the content of this article.The analysis of serum TFPI2, CA125, CA19-9, and CEA levels was outsourced to the Tosoh Corporation by the Kanagawa Cancer Center.

    Techniques:

    Pearson’s correlation analysis between serum TFPI2 and CA125 levels. There was a low correlation between serum TFPI2 and CA125 levels ( r = 0.203, p < 0.001). CA, cancer antigen; TFPI2, tissue factor pathway inhibitor 2

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Pearson’s correlation analysis between serum TFPI2 and CA125 levels. There was a low correlation between serum TFPI2 and CA125 levels ( r = 0.203, p < 0.001). CA, cancer antigen; TFPI2, tissue factor pathway inhibitor 2

    Article Snippet: The other authors declare no conflicts of interest directly relevant to the content of this article.The analysis of serum TFPI2, CA125, CA19-9, and CEA levels was outsourced to the Tosoh Corporation by the Kanagawa Cancer Center.

    Techniques:

    Multivariate analysis of prognostic factors for overall survival

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Multivariate analysis of prognostic factors for overall survival

    Article Snippet: The other authors declare no conflicts of interest directly relevant to the content of this article.The analysis of serum TFPI2, CA125, CA19-9, and CEA levels was outsourced to the Tosoh Corporation by the Kanagawa Cancer Center.

    Techniques: